<qa>  What is expected to enhance the therapeutic window of peg-IFN-alpha-2bAOP2014 was shown to have a prolonged plasma half-life with a concomitant increase in AUC. This is expected to enhance the therapeutic window of peg-IFN-alpha-2b. 